Innovative nanoparticle therapy enhances recovery in severe burn patients

Severe burns can cause critical issues, including deep tissue damage and increased risk of fatal conditions like sepsis and organ failure.

Awakn Life Sciences Completes Sale of Awakn Clinics In Norway

As part of its business restructuring process and following its London clinics business sale, UK-based biotech Awakn Life Sciences Corp. AWKNF has sold its Norwegian clinics businesses in a management buyout transaction. Awakn will

August 2, 2023

Denosumab biosimilar by Sandoz Group for Bone Metastasis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Bone Metastasis.

March 19, 2024

Engrailed-1 protein promotes pancreatic cancer progression and metastasis

Pancreatic cancer is the No. 3 cause of cancer-related deaths in the United States, and only 12% of patients survive five years after being diagnosed.

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.